JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Jan.14.2025
 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Making smoking healthier and more personalized, the JR10 e-cigarette is specially designed for the UK market and future European markets. With its excellent design and attractive appearance, it stands out as a leader among smoking alternatives.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The stylish and simple JR10 e-cigarette features a semi-transparent cartridge design and colorful lights that instantly catch the eye.

 

 

Core Highlights: Long-lasting Battery Life and Powerful Performance

 

 

The JR10 is equipped with a 650mAh rechargeable battery, supporting USB-C fast charging. It can be fully charged in less than an hour, allowing you to maintain smooth use whether at home, in the office, or on the go. Coupled with a large 2+10ML semi-transparent cartridge, it supports approximately 10,000 draws, truly achieving a perfect balance of efficiency and long-lasting battery life.

 

Imagine: No need for frequent charging and oil refills, easily meeting the needs of the whole day, making your life more convenient and efficient.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The semi-transparent cartridge design, makes the oil level clear at a glance, saying goodbye to dry burns and worries; the screen displays the battery level in real-time, making use smarter.

 

 

Colorful Lights Add Fun to the Experience

 

 

Every draw lights up the semi-transparent cartridge with a rainbow of colors, providing a cool visual experience. This is not just a function but also a fashion statement, suitable for modern users who pursue personalization.

 

 

Automatic Airflow Activation Mechanism, Mouth-to-Lung (MTL) Style for a More Natural Fit

 

 

The JR10 adopts an automatic airflow activation mechanism, no button operation is needed, just pick up and use, especially suitable for users who prefer the MTL (mouth-to-lung) drawing style, with a smooth and natural draw.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
Users enjoy the JR10 effortlessly, with the MTL design closer to the traditional smoking sensation, satisfying the need for a real smoking experience.

 

 

Details are King: Thoughtful Design for Every Moment

 

  • Battery Level Screen Display: Always in control of the device status, no need to worry about the battery running out suddenly.
  • 20mg Nicotine Concentration: Precise control of nicotine cravings, meeting needs while complying with the strict regulations of the European market.
  • Semi-transparent cartridge Design: Clear oil level visibility, more worry-free use.

 

 

Born for the Future: A Dual Commitment to Safety and Environmental Sustainability

 

 

As an innovative product focused on the UK and European markets, the JR10 not only complies with local laws and health standards but also offers sustainable choices through more environmentally friendly designs.

 

The above 2+10 product is developed by Lanavape, which has not yet been officially launched on the website.

 

LANAVAPE is a well-known e-cigarette brand factory headquartered in Shenzhen, China, ranking in the top five in the Southeast Asian market and trusted by consumers. The company focuses on the research and production of disposable, Replaceable pod, and open pod-style e-cigarettes. Now, LANAVAPE is actively expanding into the European market, offering healthier and more efficient smoking alternatives to users worldwide.

Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Several U.S. states have incorporated the September 9, 2020 PMTA filing deadline into eligibility rules for certain vaping products. CrossBar 20K drew attention after appearing on Pennsylvania's 163-entry directory. A broader 2Firsts investigation found that related registration businesses also listed KUMI and CROSSBAR SIX products, with 171 KUMI-related entries across Louisiana, Nebraska and Wisconsin. Corporate records link Scott Silverman to Blue Nine LLC and VR Products I LLC. PMTA compliance expert Mr. K said historical applications and nicotine-analogue products may offer two different approaches to state-directory access.
Regulations
Oct.26
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
BAT Adds Former Apple General Counsel Bruce Sewell to Board as Finance, Legal, Marketing and Regional Leadership Shift
BAT Adds Former Apple General Counsel Bruce Sewell to Board as Finance, Legal, Marketing and Regional Leadership Shift
British American Tobacco has appointed former Apple Senior Vice President, General Counsel and Secretary Bruce Sewell as an independent non-executive director, effective January 1, 2027. He will also join BAT's Audit and Nominations Committees. BAT Chair Luc Jobin highlighted Sewell's experience in technology, government and regulatory affairs, public-company governance and AI-company boards. Over the past 18 months, BAT has changed or announced changes to its CFO, general counsel, CMO and APMEA regional leadership, while the main board has also seen multiple changes. The appointment comes as BAT advances Horizon 2030 and its Fit2Win transformation while expanding New Categories and reshaping parts of its digital, technology and operating structure.
Business
Oct.29
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23